GARCIA PETER S

Average Profitability
43.32%
Insider Buys Quantity
4
Insider Buys Sum
$222,775.40
Insider Sells Quantity
8
Insider Sells Sum
$6.57M

Insider Activity of GARCIA PETER S

According to the SEC Form 4 filings, GARCIA PETER S, being in a position of

  1. CHIEF FINANCIAL OFFICER at ALX Oncology Holdings Inc.,
    оver the last 12 months, has bought 12000 shares for $102,338, and sold 1893 shares for $28,471,
    over all time since 2020-07-21, has bought 18000 shares for $159,338, and sold 93673 shares for $6.57M.

The largest purchase of all time was on 2024-06-13 and amounted to 12000 shares of ALX Oncology Holdings Inc. for $102,338.

The largest sale of all time was on 2021-08-23 and amounted to 60000 shares of ALX Oncology Holdings Inc. for $4.45M.

Biography of GARCIA PETER S

No biography is available at this moment.

2024-06-13PurchaseALX Oncology Holdings Inc.
ALXO
CHIEF FINANCIAL OFFICER
12,000
0.0229%
$8.53$102,338-73.93%
2023-12-29SaleALX Oncology Holdings Inc.
ALXO
Chief Financial Officer
1,893
0.0038%
$15.04$28,471-23.14%
2023-06-30SaleALX Oncology Holdings Inc.
ALXO
Chief Financial Officer
887
0.0021%
$7.34$6,511+24.9%
2022-12-29SaleALX Oncology Holdings Inc.
ALXO
Chief Financial Officer
893
0.0021%
$11.07$9,886-40.71%
2021-10-18SaleALX Oncology Holdings Inc.
ALXO
Chief Financial Officer
7,229
0.0182%
$55.44$400,793-73.46%
2021-09-17SaleALX Oncology Holdings Inc.
ALXO
Chief Financial Officer
11,345
0.0285%
$78.96$895,811-79.71%
2021-09-16SaleALX Oncology Holdings Inc.
ALXO
Chief Financial Officer
1,426
0.0035%
$80.43$114,695-80.45%
2021-08-23SaleALX Oncology Holdings Inc.
ALXO
Chief Financial Officer
60,000
0.1516%
$74.15$4.45M-76.24%
2021-08-17SaleALX Oncology Holdings Inc.
ALXO
Chief Financial Officer
10,000
0.0239%
$66.23$662,299-74.14%
2020-07-21PurchaseALX Oncology Holdings Inc.
ALXO
Chief Financial Officer
6,000
0.0062%
$9.50$57,000+90.48%
2012-03-19PurchaseLineage Cell Therapeutics, Inc.
LCTX
Chief Financial Officer
10,000
0.0199%
$4.68$46,757-10.81%
2011-11-29PurchaseLineage Cell Therapeutics, Inc.
LCTX
Chief Financial Officer
4,000
0.008%
$4.17$16,680+3.14%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.